Cromos Pharma is a US based international contract research organization

insights

News

Free Feasibility, Free Feasibility Report, Multicountry Free Feasibility Report

Cromos Pharma’s Free Multicountry Feasibility Report

21 Sep 2023

We invite you to take advantage of Cromos Pharma’s Free Multicountry Feasibility Report for your ongoing or upcoming clinical trial. You will get: Competitive trials landscape Review of local standards of care Historical recruitment analysis Regulatory requirements and timelines Realistic recruitment projections. The accuracy of Cromos Pharma’s Multicountry Report is backed by its proprietary “No Patients – No Payment” risk sharing model where you only pay if we deliver on our...

Cancer research challenges in Ukraine

07 Sep 2023

In this article featured in Nature Journal, Vlad Bogin, MD, FACP, CEO of Cromos Pharma, offers insights into the prevailing challenges of conducting cancer research in...

Happy Labor Day 2023

01 Sep 2023

On this special day, we celebrate the hard work and dedication of workers everywhere. It’s a time to relax, unwind, and enjoy the fruits of your labor. From Cromos Pharma, we wish you a delightful Labor Day filled with relaxation, joy, and quality time with loved ones. May this day rejuvenate you for the challenges and triumphs that lie ahead. Happy Labor...

Cromos Pharma commences a pivotal multicountry clinical trial of OT-101 in patients with advanced pancreatic cancer

24 Aug 2023

Cromos Pharma is thrilled to announce the commencement of a pivotal trial, focused on the investigation of OT-101, a collaborative effort between Oncotelic Therapeutics and Sapu Bioscience, in individuals suffering from advanced and unresectable or metastatic pancreatic cancer. With this ambitious multicountry endeavor, Cromos Pharma’s aspiration is to deliver a long-awaited enhancement in survival outcomes for patients afflicted by this devastating illness. Please read a press release here...

Empowering Patient Recruitment with Cromos Pharma: The Invaluable Role of Explainer Videos

15 Aug 2023

In today’s fast-moving world, visual information holds a unique power to simplify complex ideas and connect deeply. This becomes especially important when communicating with patients who need to navigate the intricate world of clinical trials. Each trial comes with its own complexities, and we need a way to present them in an easily understandable manner. This is where Cromos Pharma’s Audiovisual Department steps in as a valuable partner. Our skilled medical writers can turn even...

Hemochromatosis Screening And Awareness Month

13 Jul 2023

Hemochromatosis: the Silent Iron Overload Disorder Hemochromatosis, a hereditary disorder characterized by excessive iron absorption and accumulation in the body, often goes undiagnosed or misdiagnosed due to its subtle symptoms. By understanding hemochromatosis, individuals can recognize the warning signs and seek appropriate medical attention, potentially preventing serious complications associated with iron overload. Screening for Hemochromatosis: Early detection of hemochromatosis is...

Cromos Pharma’s CEO to present at the 18th BioPharma Clinical Trials Nexus Conference, which is set to take place October 17-18, 2023 in Philadelphia, USA.

Meet Cromos Pharma at the 18th Biopharma Clinical Trials Nexus Conference

18 Sep 2023

Cromos Pharma’s CEO to present at the 18th BioPharma Clinical Trials Nexus Conference, which is set to take place October 17-18, 2023 in Philadelphia, USA. Cromos Pharma’s CEO Vlad Bogin, MD, FACP will be participating as a moderator in the panel discussion “Empowering and Advocating for patients in Clinical Trials”. Dr. Bogin is eager to connect with potential partners and clients to gain insights into their clinical development initiatives. You can reach out directly to us...

Meet Cromos Pharma at the Global Site Solutions Summit 2023!

13 Sep 2023

We are delighted to announce that our Chief Operating Officer, Stephanie Finnegan, will be participating in the upcoming Global Site Solutions Summit, scheduled for October 6-8 in Hollywood, Florida. The Summit serves as a unique gathering point where site professionals, sponsors, CRO executives, and regulators converge to exchange best practices, foster innovative ideas, and cultivate strategic partnerships through interactive sessions, workshops, and focus groups. Stephanie will be readily...

Meet Cromos Pharma at the Clinical Operations in Oncology Trials East Coast 2023!

05 Jul 2023

Cromos Pharma will be participating in the Clinical Operations in Oncology Trials East Coast, which is set to take place July 11-12, 2023 in Boston, MA. Cromos Pharma’s CEO Vlad Bogin, MD, FACP is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. Bringing together clinical operations experts from oncology pharma and biotech sponsor...

Cromos Pharma’s CEO Participated as a Speaker in the BioPharma Nexus Conference

19 Jun 2023

Cromos Pharma’s CEO, Vlad Bogin, took part in the 17th BioPharma Nexus Conference. He participated as a speaker in the panel discussion “How to put Patients in the Heart of Clinical Trials & Daily Practice?” “Patient centricity is a critical topic in today’s clinical research,” opined Dr. Bogin. I truly enjoyed the discussion with a very knowledgeable panel of biopharma professionals”. We were excited to participate in this European event and look forward to the opportunity to take part...

Meet Cromos Pharma at the Clinical Trials Nexus Conference!

18 May 2023

Cromos Pharma will be participating in the Clinical Trials Nexus Conference, which is set to take place June 15-16, 2023 in Amsterdam. Cromos Pharma’s CEO Vlad Bogin, MD, FACP is looking forward to meeting partners and potential clients to hear about their clinical program plans. Reach out to us directly at inquiry@cromospharma.com to set up a meeting to discuss your clinical programs. Clinical Trials Nexus is a conference that brings together key decision-makers and senior clinical trials...

Meet Cromos Pharma at the BIO International Convention 2023!

11 May 2023

Cromos Pharma’s CEO Vlad Bogin, MD, FACP, and US Business Development Director, Nicole Brenna, are delighted to be taking part in the BIO International Convention, June 5-8 in Boston, MA. It’s always an event that delivers featuring presentations from leading pharma and biotech players. We are looking forward to sharing with you our experience and expertise in managing all aspects of clinical trials and how our solutions accelerate the drug development process. Reach out to us directly...

Clinical Research Focus. 20th Edition

05 Sep 2023

After Receiving First GMO Clinical Trial Approval in Georgia, Cromos Pharma Reflects on Complex International Regulatory Landscape for GMO Research Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial in Georgia. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a comprehensive reflection of the intricate regulatory landscape governing GMO...

EMA Releases a Reflection Paper on the Role of AI in Drug Development

31 Aug 2023

The European Medicines Agency (EMA) has released a reflection paper outlining its thoughts on integrating artificial intelligence (AI) in supporting the progression, oversight, and utilization of human and veterinary medicines. This document covers AI’s application from drug discovery to post-authorization. Part of the HMA-EMA Big Data Steering Group’s efforts, this paper is a collaborative endeavor involving EMA’s Committee for Medicinal Products for Human Use (CHMP) and...

Regulatory Landscapes of GMO Research Programs | Cromos Pharma

Cromos Pharma Contemplates Complex International GMO Research Program Regulations

23 Aug 2023

Cromos Pharma has received the groundbreaking approval to conduct the first Genetically Modified Organism (GMO) clinical trial. This pioneering accomplishment not only underscores the company’s commitment to scientific advancement but also prompts a comprehensive reflection of the intricate regulatory landscape governing GMO trials in the US and EU. Initiating the first GMO clinical trial in Georgia presented a notable challenge Absence of prior GMO studies conducted in Georgia...

Decentralized Clinical Trials | Cromos Pharma

Decentralized Clinical Trials: Balancing the Promise and Pitfalls in Cost, Recruitment, and Patient Satisfaction

17 Aug 2023

Decentralized clinical trials (DCTs) have emerged as a transformative solution in clinical research, leveraging remote technologies to streamline processes, boost patient satisfaction, and expedite recruitment. However, the potential pitfalls of increased costs and compromised recruitment and patient satisfaction warrant careful consideration by biotech professionals. This synthesis delves into the complex landscape of DCTs, addressing both their promise and the challenges they present. The...

Clinical Research Focus. 19th Edition

03 Aug 2023

Addressing the Underrepresentation of Older Adults in Cancer Clinical Trials: Advancing Inclusion for Improved Care The underrepresentation of older patients in cancer clinical trials poses a significant concern as it limits the generalizability of trial results to the broader population, particularly older adults who are affected by cancer more frequently. Various factors contribute to the exclusion of older participants, including age-related eligibility criteria, preexisting conditions...

Advancing Clinical Trial Diversity: A Step Towards Equitable Healthcare

01 Aug 2023

The lack of diversity in clinical trials has long been a concern, leading to adverse side effects and health disparities among various racial and ethnic groups, as well as women. Historically, clinical trials have disproportionately included white men as participants, which limited our understanding of how drugs and treatments affect different populations. This article explores the reasons for the lack of diversity in clinical trials and examines the steps being taken to promote inclusivity...

Cromos pharma: international CRO

Cromos Pharma: International CRO

No Patients No Payment

No Patients No Payment

Free Multicountry Feasibility Report

Free Multicountry Feasibility Report

Advancing Clinical Trial Diversity

Advancing Clinical Trial Diversity

Clinical research focus. 20th edition

Clinical research focus. 20th edition

Clinical Trialsin the Czech Republic

Clinical Trialsin the Czech Republic

Patient recruitment

Clinical Research Services

Regulatory Services

EU legal representation

Medical Writing

Data Management

CTM Logitics

PV Support

Independent Audits